30-day Mortality | Univariable analysis | Multivariable analysis | |||||
---|---|---|---|---|---|---|---|
Odds ratio | 95% CI | p-value | Odds ratio | 95% CI | p-value | ||
Age | – | 1.02 | 1.01–1.03 | 0.001* | 1.04 | 1.02–1.05 | < 0.001* |
Male | 192 (38.5%) | 1.08 | 0.80–1.46 | 0.61 | |||
Solid malignancy (ref) | 176 (35%) | ||||||
Hematological malignancy | 117 (42.7%) | 1.39 | 1.02–1.87 | 0.03* | 1.63 | 1.02–2.60 | 0.04* |
Metastatic disease | 101 (41.2%) | 1.23 | 0.91–1.68 | 0.19 | 1.05 | 0.56–1.96 | 0.89 |
Cancer recurrence | 32 (45.1%) | 1.39 | 0.85–2.27 | 0.19 | 1.39 | 0.74–2.60 | 0.31 |
Controlled cancer (ref) | 98 (26.4%) | ||||||
Uncontrolled cancer | 197 (48.3%) | 2.60 | 1.92–3.52 | < 0.001* | 2.30 | 1.54–3.41 | < 0.001* |
CCI | – | 1.08 | 1.01–1.15 | 0.02* | 1.02 | 0.89–1.15 | 0.82 |
ECOG PS before hospital admission | |||||||
0 (ref) | 47 (26%) | ||||||
1 | 107 (35.9%) | 1.60 | 1.06–2.40 | 0.02* | 1.33 | 0.81–2.18 | 0.27 |
2 | 82 (42.9%) | 2.15 | 1.38–3.33 | 0.001* | 1.84 | 1.07–3.19 | 0.03* |
3 | 44 (48.9%) | 2.73 | 1.61–4.64 | < 0.001* | 2.40 | 1.21–4.77 | 0.01* |
4 | 13 (86.7%) | 18.53 | 4.03–85.19 | < 0.001* | 12.42 | 2.34–65.93 | 0.003* |
MEWS | 1.13 | 1.05–1.20 | < 0.001* | 1.13 | 1.04–1.23 | 0.006* | |
Cancer treatment | 252 (36.8%) | 0.77 | 0.50–1.20 | 0.25 | |||
Immunocompromised | 214 (38.2%) | 1.09 | 0.79–1.51 | 0.61 | |||
ICU triage decision | |||||||
ICU admission (ref) | 141 (36.9%) | ||||||
Too well to benefit—no ICU admission | 66 (25.6%) | 0.59 | 0.42–0.83 | 0.003* | 0.66 | 0.42–1.04 | 0.08 |
Too well to benefit—delayed ICU | 34 (45.9%) | 1.45 | 0.88—2.40 | 0.15 | 1.83 | 1.00—3.33 | 0.048* |
Too sick to benefit | 54 (81.8%) | 7.69 | 3.98–14.87 | < 0.001* | 7.78 | 3.38–17.89 | < 0.001* |
Year ICU consult | |||||||
2016 (ref) | 78 (36.4%) | – | – | – | |||
2017 | 77 (37.7%) | 1.06 | 0.71–1.57 | 0.78 | |||
2018 | 87 (39.2%) | 1.12 | 0.76–1.66 | 0.56 | |||
2019 | 53 (37.9%) | 1.06 | 0.68–1.65 | 0.79 | |||
Earlier ICU admission before consult | 18 (23.4%) | 0.47 | 0.27–0.81 | 0.007* | 0.82 | 0.41–1.64 | 0.57 |
One ICU physician (ref) | 109 (34.3%) | ||||||
Two ICU physicians | 155 (40.3%) | 1.29 | 0.95–1.76 | 0.10 | 0.97 | 0.64–1.46 | 0.87 |
More than two ICU physicians | 31 (40.3%) | 1.29 | 0.78–2.15 | 0.33 | 0.95 | 0.48–1.87 | 0.88 |
One referring physician (ref) | 53 (32.3%) | ||||||
Two referring physicians | 195 (39.3%) | 1.36 | 0.93–1.97 | 0.11 | 1.27 | 0.80–2.03 | 0.31 |
More than two referring physicians | 45 (39.8%) | 1.39 | 0.84–2.28 | 0.20 | 1.24 | 0.64–2.38 | 0.53 |
Location consult | |||||||
Emergency room (ref) | 57 (41.6%) | – | – | – | |||
Ward | 188 (38.9%) | 0.89 | 0.61–1.32 | 0.57 | 1.42 | 0.86–2.35 | 0.18 |
Other | 50 (31.3%) | 0.64 | 0.40–1.03 | 0.07 | 1.70 | 0.90–3.20 | 0.10 |
On-hours (ref) | 103 (32.7%) | ||||||
Off-hours | 192 (41.3%) | 1.45 | 1.07–1.95 | 0.02* | 1.61 | 1.09–2.38 | 0.02* |
Weekend | 95 (38.9%) | 1.07 | 0.79–1.46 | 0.67 | |||
Consult reason | |||||||
Shock | 68 (45.3%) | 2.49 | 1.48–4.19 | 0.001* | 1.78 | 0.97–3.26 | 0.06 |
Respiratory insufficiency | 188 (38.9%) | 1.48 | 1.02–2.17 | 0.04* | 1.18 | 0.77–1.83 | 0.45 |
Altered consciousness | 68 (48.9%) | 2.12 | 1.35–3.34 | 0.001* | 1.73 | 1.06–2.83 | 0.03* |
Sepsis | 87 (40.7%) | 1.28 | 0.84–1.97 | 0.25 | |||
Acute kidney injury | 50 (53.2%) | 2.70 | 1.65–4.41 | < 0.001* | 2.47 | 1.41–4.34 | 0.002* |
High MEWS | 10 (43.5%) | 1.93 | 0.80–4.64 | 0.14 | 2.00 | 0.70–5.72 | 0.20 |
Hemodynamic instability | 102 (36.4%) | 0.69 | 0.42–1.14 | 0.15 | 0.70 | 0.42–1.18 | 0.18 |
Other | 34 (35.4%) | 1.14 | 0.70–1.87 | 0.59 |